Genmab (GMAB) net assets (shareholders' equity)

Net assets · fiscal 2025
$5.85B

Genmab (GMAB) had net assets of $5.85B at the end of fiscal 2025 (December 31, 2025). That is 13.8% higher than the $5.14B of fiscal 2024. Figures as of 19 Nov 2026, 04:49 UTC, from Yahoo Finance.

Key facts

Net assets, fiscal 2025
$5.85B
Change on fiscal 2024
+13.8%
Highest on record
$5.85Bfiscal 2025
Lowest on record
$3.93Bfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

Genmab net assets (shareholders' equity), in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $5.85B in fiscal 2025 and the lowest $3.93B in fiscal 2022.

History · 4 fiscal years

Net assets by fiscal year

Genmab net assets (shareholders' equity), year by year

Genmab (GMAB) net assets (shareholders' equity) by fiscal year
Fiscal yearNet assetsChangeYear ended
2025$5.85B 13.8% up
2024$5.14B 9.6% up
2023$4.69B 19.4% up
2022$3.93B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value.

How to read it

Large buybacks and write-offs shrink it without the business getting worse, so a falling or negative figure needs the reason before a verdict.

Net assets at health care companies of similar size

Net assets of Genmab and comparable companies
CompanyNet assetsFiscal year
Mettler-Toledo International MTD-$23.64M2025
Centene CNC$19.95B2025
Genmab GMAB$5.85B2025
Illumina ILMN$2.72B2025
ResMed RMD$6.59B2026
Zoetis ZTS$3.33B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on GMAB

Genmab, figure by figure

Genmab (GMAB) overview: price, valuation and scorecardAll health care companies by market value

Genmab net assets (shareholders' equity): questions and answers

What are Genmab's net assets?

Genmab (GMAB) had net assets of $5.85B at the end of fiscal 2025 (December 31, 2025). That is 13.8% higher than the $5.14B of fiscal 2024.

What are the highest and lowest net assets figures on record for Genmab?

Across the 4 fiscal years on record (2022–2025), the highest was $5.85B in fiscal 2025 and the lowest $3.93B in fiscal 2022.

How is Genmab's net assets calculated?

Net assets is shareholders' equity on the balance sheet at the fiscal year-end: total assets minus total liabilities, also called book value. For Genmab it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Genmab (GMAB) net assets (shareholders' equity)”, data as of 19 November 2026. https://funkfolio.com/stock/GMAB/net-assets

Underlying data: Yahoo Finance.